Pharmaceutical R&D and IP commercialisation gain momentum in Ghana

Eight Ghanaian research-industry partnerships have received €2 million in grants under the PharmaVax Ghana programme to advance vaccine and pharmaceutical R&D, including projects involving malaria treatments and AI-assisted antibody discovery. The programme is intended to help translate research into locally manufactured health products for Ghana and regional markets, with IP protection and technology transfer identified as important components in moving innovations from the laboratory to commercial production.

The grants were announced at a “Research Meets Manufacturing” ceremony jointly hosted by Ghana’s National Vaccine Institute and GIZ, with funding from the German Federal Ministry for Economic Cooperation and Development and the European Union. The initiative forms part of Ghana’s broader efforts to develop domestic pharmaceutical manufacturing capacity and reduce reliance on imported medicines and vaccines.

View Related Blogs
View All
news

OAPI celebrates local innovation

The 10th edition of the African Exhibition of Invention and Innovative Enterprise (SAIIT) was held in Niamey, Niger, in early October. The exhibition recognised local inventors and entrepreneurs whose...

Adams NewsAfrica Ip updatesOAPI
news

ARIPO @ 50’s Symposium on Copyright and Related Rights

The African Regional Intellectual Property Organization (ARIPO) and the World Intellectual Property Organization (WIPO), in collaboration with the Uganda Registration Services Bureau (URSB), co-organi...

Adams NewsAfrica Ip updatesARIPO
news

OAPI and OEPM support Equatorial Guinea’s IP development

The African Intellectual Property Organization (OAPI) and the Spanish Patent and Trademark Office (OEPM) participated in a joint mission to support Equatorial Guinea in developing a strategic vision f...

Adams NewsAfrica Ip updatesOAPI